Keyphrases
Vitamin C
85%
DNA Methyltransferase Inhibitor
81%
Myeloid Cancer
66%
Hypomethylating Agents
56%
5-hydroxymethylcytosine (5hmC)
50%
Myelodysplastic Syndrome
40%
Combined Targeting
33%
Azacitidine
33%
DNA Methylation (DNAm)
33%
Azacytidine
33%
T Cells
33%
5-aza-2′-deoxycytidine
33%
Vitamin C Supplementation
33%
Hematologic Neoplasms
33%
Dysplastic Changes
33%
Idiopathic Cytopenia of Undetermined Significance
33%
New Players
33%
Epigenetic Modification
33%
Plasma Vitamin C
33%
Hypomethylation
33%
Programmed Death-ligand 1 (PD-L1)
33%
Vitamin C Deficiency
30%
Ten-eleven Translocation Enzymes
16%
SRSF2
16%
Patients with Cancer
15%
DNA Demethylation
15%
Epigenetic Therapy
15%
Biochemistry, Genetics and Molecular Biology
Vitamin C
100%
Azacitidine
66%
Myeloid
55%
Epigenetics
50%
DNA Methylation
35%
Vitamin Blood Level
33%
Upregulation
33%
Decitabine
33%
T Cell
33%
Mutated Genes
33%
Epigenome
33%
DNA Methyltransferase
31%
Promoter Region
26%
Demethylation
25%
5-Methylcytosine
17%
ASXL1
16%
DNMT3A
16%
5-Hydroxymethylcytosine
15%
Medicine and Dentistry
Ascorbic Acid
100%
Malignant Neoplasm
100%
DNA Methyltransferase Inhibitor
77%
Hypomethylating Agent
40%
Azacitidine
33%
Supplementation
33%
Decitabine
33%
Ascorbic Acid Deficiency
28%
5 Methylcytosine
22%
5 Hydroxymethylcytosine
19%
DNA Demethylation
17%
Cancer
16%
Neoplasm
16%
In Vitro
15%
Epigenetic Therapy
15%
Myelodysplastic Syndrome
15%
